AFP and hepatocellular carcinoma: In this biobank-based case–control study, we comprehensively evaluated the diagnostic performances of individual serum biomarkers (AFP, AFP-L3, DCP) and composite scoring models (GALAD, GAAP, ASAP, aMAP, and Doylestown) for detecting HCC in different clinical settings.